Matthew K. Summers
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
97
Citations
2,120
Est. group size
~2
Recurring co-author estimate
Active years
25
Publishing since 2001
Matthew K. Summers studies how cells divide, focusing on the molecular machinery that controls mitosis (cell division) and ensures chromosomes are correctly distributed to daughter cells. His work examines proteins like NEK2, LIN9, CDH1, and KIF11 that regulate this process, with an eye toward how disrupting them could improve cancer treatments, including for glioblastoma and taxane-resistant tumors. This research sits at the intersection of basic cell biology and translational cancer therapeutics.
Publication output was moderate and fluctuating from 2017-2022, then spiked sharply in 2023 (largely due to a single multi-part study with many associated supplementary files) before dropping off in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- p31Comet Splice Variants Induce Distinct Spindle Assembly Checkpoint Dynamics due to Their Unique N-Termini
International Journal of Molecular Sciences · 2025
- Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11
Cancers · 2023
- Data from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Data from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S5 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S6 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S1 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S4 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Supplementary Materials from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S3 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S2 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S6 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S2 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Figure S3 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Supplementary Materials from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023
- Cancer Research×6
- Neuro-Oncology×5
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Molecular Cancer Research×2
- Veterinary and Comparative Oncology×2
- Claire Walczak
Biochemistry, Genetics and Molecular Biology · Indiana University
- Stephanie C. Ems-McClung
Biochemistry, Genetics and Molecular Biology · Indiana University
- Brian H. Lee
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- David A. Kellough
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Gisela Cairo
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile